¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ëÀåÇ×¹®ÇÐȸ International Colorectal Research Summit 2022 (3ÀÏÂ÷) : 2022-09-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ëÀåÇ×¹®ÇÐȸ International Colorectal Research Summit 2022 (3ÀÏÂ÷) : 2022-09-04
±³À°ÀÏÀÚ : 2022-09-04
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) International Colorectal Research Summit 2022 (3ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ
´ã´çÀÚ : ±è¼ö¿¬
¿¬¶ôó : 02-2040-7737  
À̸ÞÀÏ : colon@kams.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 140,000¿ø      
ºñ°í Early Registration: Members KRW 100,000 Military Doctor/Resident KRW 30,000 Nurse KRW 50,000 NON-Members KRW 120,000 / On-site Registration: Members KRW 120,000 Military Doctor/Resident KRW 50,000 Nurse KRW 70,000 NON-Members KRW 140,000 One Day Fee(9/4 or 5) : Early Bird Members KRW 70,000 / On-site Registration NON-Members KRW 80,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-04 room2 08:30~08:50 Resectable Metastasis Colon: Chemotherapy First vs. Surgery First  ±è¿µÀÏ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 08:50~09:10 Resectable Metastasis Rectum: Is There the Role of Neoadjuvant Short-Course RT?  º¯È­°æ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 09:10~09:30 Conversion Strategies for Unresectable Liver Metastases  ±èÁö¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 09:30~09:50 Management of Disappeared Liver Metastasis  ¼Û°æµÎ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 09:50~10:10 Case Presentation  ÀÌÁ¾·ü(¿ï»êÀÇ´ë) 
È޽Ġ09-04 room2 10:10~10:40 Break  () 
±³À°½Ã°£ 09-04 room2 10:40~11:00 Peritoneal Carcinomatosis in Colorectal Cancer: Biology and Barriers  ±èâÇö(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 11:00~11:20 Pharmacokinetics of HIPEC and PIPAC: Is There the Rationale?  ¹Úµ¿±¹(´Ü±¹ÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 11:20~11:40 Lessons Leared PRODIGE 7  ±è¿ì¶÷(Æ÷õÁß¹®ÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 11:40~12:00 Cytoreductive Surgery with HIPEC and PIPAC  ¹ÚÀºÁ¤(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-04 room2 12:00~12:20 Case Presentation  ÀÓ´ë·Î(¼øõÇâÀÇ´ë) 
½Ä»ç 09-04 room2 12:20~13:20 ·±Ãµ½ÉÆ÷Áö¾ö  ±¹³»¿¬ÀÚ() 
±³À°½Ã°£ 09-04 room2 13:20~13:40 Low Anterior Resection Syndrome  ±è¹ÎÁ¤(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 13:40~14:00 Genitourinary Sequelae in Rectal Cancer Survivors  ¹ÚÇöÁØ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 14:00~14:20 Chemotherapy and Radiotherapy Related Problems  À̼ö¿µ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 14:20~14:40 Screening of Second Malignancy  ¹ÚÁö¼ö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 14:40~15:00 Well-being after Colorectal Cancer Treatment  ¹é¼¼Áø(°í·ÁÀÇ´ë) 
È޽Ġ09-04 room2 15:00~15:30 Break  () 
±³À°½Ã°£ 09-04 room2 15:30~15:50 Primary Tumor Resection Versus Chemotherapy for CRC Unresectable Metastases (JCOG1007 iPACS)  Yukihide KANEMITSU(National Cancer Center Hospital Japan) 
±³À°½Ã°£ 09-04 room2 15:50~16:10 Open vs Laparoscopic Surgery for Mid/Low Rectal Cancer After LCRT (COREAN Trial)  ¹ÚÁö¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 16:10~16:30 Systemic Chemotherapy with or without Cetuximab in Resectable CRLM (NEW EPOC Trial)  John PRIMROSE(University of Southhampton UK) 
±³À°½Ã°£ 09-04 room2 16:30~16:50 Multicenter, Randomized Single-port versus Multiport Laparoscopic Surgery (SIMPLE) Trial in Colon Cancer  °­º´¸ð(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-04 room2 16:50~17:10 Quality of Life after Sphincter Preservation Surgery or Abdominoperineal Resection for Low Rectal Cancer (ASPIRE): A Long-term Prospective, Multicentre, Cohort Study  °­¼º¹ü(¼­¿ïÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ International Colorectal Research Summit 2022 (3ÀÏÂ÷) : 2022-09-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼øõÇâ´ëÇб³ºÎõº´¿ø ³»½Ã°æ.ÃÊÀ½ÆÄ ¶óÀÌºê ½ÉÆ÷Áö¾ö 2022 : 2022-09-04
´ÙÀ½±Û 2022³â ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ Knee Symposium : 2022-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20889 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 121 2024-05-27
20888 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 35 2024-05-27
20887 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 23 2024-05-27
20886 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 25 2024-05-27
20885 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 44 2024-05-27
20884 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 13 2024-05-27
20883 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 21 2024-05-27
20882 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 12 2024-05-27
20881 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 18 2024-05-27
20880 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 22 2024-05-27
20879 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 21 2024-05-27
20878 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 20 2024-05-27
20877 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 13 2024-05-27
20876 ¼­¿ï 2024³â ´ëÇÑÇǺÎÁø±Õ ¹× °¨¿°ÇÐȸ Á¦3ȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 13 2024-05-27
20875 ¼­¿ï °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸ ILD School 202 : 2024-06-29 0 10 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷